NFA
ALXN
Nationwide Fund Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-181,165
| Closed | -$25.4M | – | 2559 |
|
|
2017
Q3 | $25.4M | Sell |
181,165
-8,655
| -5% | -$1.21M | 0.1% | 221 |
|
|
2017
Q2 | $23.1M | Sell |
189,820
-52,278
| -22% | -$6.36M | 0.09% | 261 |
|
|
2017
Q1 | $29.4M | Buy |
242,098
+14,819
| +7% | +$1.8M | 0.12% | 179 |
|
|
2016
Q4 | $27.8M | Buy |
227,279
+132,235
| +139% | +$16.2M | 0.12% | 188 |
|
|
2016
Q3 | $11.6M | Sell |
95,044
-1,633
| -2% | -$200K | 0.05% | 545 |
|
|
2016
Q2 | $11.3M | Sell |
96,677
-66,416
| -41% | -$7.75M | 0.05% | 528 |
|
|
2016
Q1 | $23.7M | Sell |
163,093
-18,790
| -10% | -$2.73M | 0.1% | 224 |
|
|
2015
Q4 | $34.7M | Sell |
181,883
-115,215
| -39% | -$22M | 0.15% | 139 |
|
|
2015
Q3 | $46.5M | Sell |
297,098
-8,984
| -3% | -$1.41M | 0.21% | 81 |
|
|
2015
Q2 | $55.3M | Buy |
306,082
+49,621
| +19% | +$8.97M | 0.23% | 74 |
|
|
2015
Q1 | $44.4M | Sell |
256,461
-22,936
| -8% | -$3.97M | 0.18% | 107 |
|
|
2014
Q4 | $51.7M | Sell |
279,397
-51
| -0% | -$9.44K | 0.22% | 75 |
|
|
2014
Q3 | $46.3M | Sell |
279,448
-32,493
| -10% | -$5.39M | 0.2% | 92 |
|
|
2014
Q2 | $48.7M | Buy |
+311,941
| New | +$48.7M | 0.2% | 94 |
|
|
2014
Q1 | – | Sell |
-327,476
| Closed | -$43.6M | – | 3231 |
|
|
2013
Q4 | $43.6M | Buy |
327,476
+12,987
| +4% | +$1.73M | 0.18% | 108 |
|
|
2013
Q3 | $36.5M | Sell |
314,489
-39,258
| -11% | -$4.56M | 0.16% | 121 |
|
|
2013
Q2 | $32.6M | Buy |
+353,747
| New | +$32.6M | 0.17% | 104 |
|